We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Jason A. Wietjes Bracewell & Giuliani LLP

Results 1 to 5 of 6



New USPTO Dallas-Fort Worth regional satellite office finds home in downtown Dallas location *

USA - November 30 2012
The US Patent and Trademark Office (USPTO) recently announced that downtown Dallas will serve as the site for its Dallas-Fort Worth regional satellite office.

Co-authors: Michael D. Pegues, R. Casey O'Neill.


New America Invents Act provisions set to become effective in September 2012 *

USA - August 22 2012
The switch to a modified first-inventor-to-file system will not take place until March 16, 2013, but notably several provisions of the Leahy-Smith America Invents Act (AIA) will take effect in one month, on September 16, 2012.

Co-authors: Michael D. Pegues, Jeffrey S. Whittle, R. Casey O'Neill.


USPTO opens a satellite patent office in Dallas *

USA - July 2 2012
On July 2, 2012, the United States Patent and Trademark Office (USPTO) announced the selection of Dallas, Texas as the location for one of its satellite patent offices, and it was the sole southern city chosen.

Co-authors: Michael D. Pegues.


Can't touch this - Supreme Court finds personalized medicine patent claims invalid *

USA - March 20 2012
In Mayo Collaborative Services v. Prometheus Laboratories, Inc., the Supreme Court of the United States held unanimously that claims directed to a method of altering a drug dose based on levels of the drug’s metabolite are ineligible for patent protection under section 101 of the patent statute

Co-authors: Michael R. Samardzija, Ph.D., Jeffrey S. Whittle.


Ariad v. Eli Lilly: Federal Circuit confirms separate written description and enablement requirements for patents *

USA - March 24 2010
In one of the more anticipated and closely watched cases of the year, the U.S. Court of Appeals for the Federal Circuit has confirmed in an en banc decision that patents must meet both written description and enablement requirements under 35 U.S.C. §112 (1975).

Co-authors: Michael R. Samardzija, Ph.D., Michael D. Pegues, Jeffrey S. Whittle.


Next »